SG Americas Securities’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,210
| Closed | -$89K | – | 2529 |
|
|
2025
Q1 | $89K | Buy |
25,210
+9,252
| +58% | +$32.7K | ﹤0.01% | 2732 |
|
|
2024
Q4 | $60K | Sell |
15,958
-41,428
| -72% | -$156K | ﹤0.01% | 2549 |
|
|
2024
Q3 | $186K | Buy |
57,386
+1,550
| +3% | +$5.02K | ﹤0.01% | 2270 |
|
|
2024
Q2 | $106K | Buy |
55,836
+29,697
| +114% | +$56.4K | ﹤0.01% | 2211 |
|
|
2024
Q1 | $74K | Sell |
26,139
-39,900
| -60% | -$113K | ﹤0.01% | 2331 |
|
|
2023
Q4 | $972K | Buy |
66,039
+44,784
| +211% | +$659K | 0.01% | 927 |
|
|
2023
Q3 | $389K | Buy |
21,255
+12,936
| +155% | +$237K | ﹤0.01% | 1768 |
|
|
2023
Q2 | $179K | Sell |
8,319
-869
| -9% | -$18.7K | ﹤0.01% | 1607 |
|
|
2023
Q1 | $270K | Sell |
9,188
-1,301
| -12% | -$38.2K | ﹤0.01% | 2006 |
|
|
2022
Q4 | $388K | Buy |
+10,489
| New | +$388K | ﹤0.01% | 1546 |
|